Physostigmine
Back to searchMolecule Structure
Scientific Name
Physostigmine
Description of the Drug
Physostigmine is a cholinesterase inhibitor used to treat glaucoma and anticholinergic toxicity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00981
http://www.drugbank.ca/drugs/DB00981
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL220 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24044 | ||
| PharmGKB | PA450957 | ||
| Human Metabolome Database | HMDB0015116 | ||
| DrugBank | DB00981 | ||
| PubChem: Thomson Pharma | 14848555 | 15222048 | |
| PubChem | 5983 | ||
| Mcule | MCULE-2638001883 | MCULE-9310809074 | |
| NMRShiftDB | 60026266 | ||
| LINCS | LSM-2558 | ||
| Nikkaji | J4.579I | ||
| BindingDB | 11023 | 50004000 | 50222010 |
| EPA CompTox Dashboard | DTXSID3023471 | ||
| DrugCentral | 2159 | ||
| Metabolights | MTBLC27953 | ||
| Brenda | 803 | 1207 | |
| ChemicalBook | CB8770121 | ||
| Guide to Pharmacology | 6598 | ||
| rxnorm | PHYSOSTIGMINE SALICYLATE | PHYSOSTIGMINE SULFATE | PHYSOSTIGMINE |
| KEGG Ligand | C06535 | ||
| ChEBI | 27953 | ||
| ZINC | ZINC000091689892 |
